About: chemotherapy regimen

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: chemotherapy regimen Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

use of two or more chemicals, simultaneously or sequentially, in the drug therapy of neoplasms

Attributes	Values
rdf:type	Item
owl:sameAs	chemotherapy regimen
description	use of two or more chemicals, simultaneously or sequentially, in the drug therapy of neoplasms (en)
rdfs:label	antineoplastic combined chemotherapy protocols (en)
skos:prefLabel	antineoplastic combined chemotherapy protocols (en)
name	antineoplastic combined chemotherapy protocols (en)
said to be the same as	wds:Q66764603-59858fad-4f5d-660f-acf5-7f41d4ff2e7c
said to be the same as	chemotherapy regimen
subclass of	wds:Q66764603-2a210358-4f54-fb59-9f1f-4cf379b86b83
subclass of	antineoplastic protocols
skos:altLabel	Antineoplastic Combined Chemotherapy Protocols (en) combined chemotherapy protocol (en)
MeSH descriptor ID	wds:Q66764603-5a0b451b-4e40-a00f-fb24-25e7a8919b3b
MeSH tree code	wds:Q66764603-40d93a3a-412d-e3bf-ee21-bc89a6b1d3c6 wds:Q66764603-6405c479-413a-fe2f-d4f5-74aa30170893 wds:Q66764603-8ebb2274-4704-a9fa-4f04-0cc4c8489060
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D000971
MeSH tree code	http://id.nlm.nih.gov/mesh/E02.183.750.500 http://id.nlm.nih.gov/mesh/E02.319.077.500 http://id.nlm.nih.gov/mesh/E02.319.310.037
MeSH descriptor ID	D000971
MeSH tree code	E02.183.750.500 E02.319.077.500 E02.319.310.037
is about of	chemotherapy regimen https://www.wikidata.org/wiki/Special:EntityData/Q66764603
is said to be the same as of	chemotherapy regimen
is said to be the same as of	wds:Q5090632-7aa2504d-4738-f4bd-9b74-808d51231f3b
is main subject of	Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy Report on the EORTC lymphoma trial 20751 Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trials Pulmonary complications of chemotherapy regimens containing bleomycin Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities Integrating BRAF/MEK inhibitors into combination therapy for melanoma. Multiple myeloma in the very elderly patient: challenges and solutions Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2 Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review) Platinum drugs in the treatment of non-small-cell lung cancer Recent treatment advances and novel therapies in pancreas cancer: a review Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis Rituximab-based treatment, HCV replication, and hepatic flares Gonadal Injury Resulting From Chemotherapy Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review). Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment Pancreatic cancer and FOLFIRINOX: a new era and new questions 4-1BB agonism: adding the accelerator to cancer immunotherapy A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs) How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies Association of response endpoints with survival outcomes in multiple myeloma First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence Combination therapy with aromatase inhibitors: the next era of breast cancer treatment? Neuroendocrine small cell rectal cancer metastasizing to the liver: a unique treatment strategy, case report, and review of the literature Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology Adjuvant therapy in resectable gastric cancer Novel agents for advanced pancreatic cancer Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer PARP inhibitors: its role in treatment of cancer Recent advances of novel targeted therapy in non-small cell lung cancer Interstitial lung disease associated with drug therapy Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer. Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study Pulmonary complications associated with combination chemotherapy programs containing bleomycin Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group Overall survival of patients with KRAS wild-type tumor treated with FOLFOX/FORFIRI±cetuximab as the first-line treatment for metastatic colorectal cancer: A meta-analysis Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer Carfilzomib/pomalidomide single-agent or in combination with other agents for the management of relapsed/refractory multiple myeloma : a meta-analysis of 37 trials VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis Oxaliplatin (L-OHP): a new reality in colorectal cancer The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis Anti-PD-1/PD-L1 antibody therapy for pretreated advanced nonsmall-cell lung cancer: A meta-analysis of randomized clinical trials Combination studies with gemcitabine in the treatment of non-small-cell lung cancer Status of adjuvant endocrine therapy for breast cancer Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer Current status of chemotherapy for the treatment of advanced biliary tract cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software